Acetylcholine regulates the development of experimental autoimmune encephalomyelitis via the CD4+ cells proliferation and differentiation-Reference-Cited by-同舟云学术

Acetylcholine regulates the development of experimental autoimmune encephalomyelitis via the CD4+ cells proliferation and differentiation

Published:2020-01-07 Issue:8 Volume:130 Page:788-803
ISSN:0020-7454
Container-title:International Journal of Neuroscience
language:en
Short-container-title:International Journal of Neuroscience

Author:

Zhou Linli¹²,Lin Xiuli¹,Ma Xiaomeng¹,Liu Yingying¹,Ma Lili¹,Chen Zhaoyu¹,Chen Hao¹,Si Lei¹,Chen Xiaohong¹

Affiliation:

1. Department of Neurology, The Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong China;

2. Epidemiology and Infection Control Section, Medical Affairs Department, The Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, China

Publisher

Informa UK Limited

Subject

General Medicine,General Neuroscience

Link

https://www.tandfonline.com/doi/pdf/10.1080/00207454.2019.1706504

Reference57 articles.

1. Multiple sclerosis animal models: a clinical and histopathological perspective

2. T cells in multiple sclerosis and experimental autoimmune encephalomyelitis

3. Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination

4. The Spatio-Temporal Expression Profiles of CD4 + T Cell Differentiation and Function-Related Genes During EAE Pathogenesis

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the Role of Neurotransmitters in Multiple Sclerosis: An Expanded Review;ACS Chemical Neuroscience;2023-02-01

2. Cholinergic control of Th17 cell pathogenicity in experimental autoimmune encephalomyelitis;Cell Death & Differentiation;2022-12-17

3. Brain-spleen axis in health and diseases: A review and future perspective;Brain Research Bulletin;2022-05

4. Role of the Cholinergic Anti-Inflammatory Reflex in Central Nervous System Diseases;International Journal of Molecular Sciences;2021-12-14

5. Targeting the gut to treat multiple sclerosis;Journal of Clinical Investigation;2021-07-01